by dkyarb | Sep 25, 2013 | Cases, Commentary
In 1989, Bayer Cropsciences filed the application that matured into US Patent #6,153,401, covering “[A] polypeptide having the biological activity of 2,4-D monooxygenase.” The enzyme they had discovered was capable of cleaving the popular herbicide 2,4-D into harmless...
by MTTLR ADMIN | Sep 22, 2013 | Commentary, Legal/Tech News, Legislation/Regulations
The legendary Patent Troll Wars will not see much of a theater in New Zealand, after Parliament just this month determined that software is no longer able to be patented in New Zealand. New Zealand’s Patent Act 2013 seeks to clean up the patent process by no...
by MTTLR ADMIN | Sep 15, 2013 | Commentary
The relationship between the developer of a show, book, or other story and a fan is usually pretty straightforward. The artist conceives, produces, and distributes a story, the fan consumes the story, and, if the fan really loves the story, consumes all sorts of...
by fmmendez | Sep 15, 2013 | Commentary
To preserve openness and a low barrier to entry, the Federal Communications Commission adopted the Open Internet Order (2010), establishing three rules for Internet Service Providers: Transparency: ISPs “must disclose” their practices and terms and conditions of their...
by bjunter | Sep 11, 2013 | Commentary, Legal/Tech News
In case you haven’t seen it, WIPO has an interesting tool that allows you look at patent data for different years and different countries. I thought it might be interesting to look at how the industries receiving patents have changed over the last 30 years. The...
by anickow | Jul 9, 2013 | Commentary
This post is written by Yoon Chae, an Associate of Baker & McKenzie *Disclaimer: This article represents the opinion of Yoon Chae as an individual and not of Baker & McKenzie as a firm. For a patent attorney, working in a city exposed to diverse patent...
